Mitochondria-Targeted Nanocarriers Promote Highly Efficient Cancer Therapy: A Review

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Mitochondria are crucial for cellular energy production (ATP) and regulate cancer cell apoptosis.
• Targeting mitochondria is a key strategy for developing effective cancer therapeutics.
• Nanocarriers show potential for combining therapeutic modalities for cancer treatment.

Purpose of the Study:

• To review lipophilic cation- and peptide-based nanosystems for mitochondria targeting in cancer therapy.
• To summarize the application of mitochondria-targeted nanocarriers in various cancer treatment modalities.
• To discuss the challenges and future directions of mitochondria-targeted nanocarriers in clinical settings.

Main Methods:

• Literature review of studies on mitochondria-targeted nanocarriers.
• Focus on lipophilic cation- and peptide-based nanosystems.
• Analysis of applications in photodynamic therapy (PDT), chemotherapy, immunotherapy, and sonodynamic therapy (SDT).

Main Results:

• Mitochondria-targeted nanocarriers enhance the efficiency of cancer treatment across multiple therapeutic modalities.
• Specific examples of lipophilic cation and peptide nanosystems demonstrate successful mitochondria targeting.
• These nanocarriers facilitate combined therapies, improving treatment outcomes.

Conclusions:

• Mitochondria-targeted nanocarriers represent a significant advancement in cancer therapy.
• Further research and development are needed to overcome challenges for clinical translation.
• Future prospects include broader applications and improved efficacy in treating various cancers.